您的位置: 首页 > 农业专利 > 详情页

Compounds to fibroblast growth factor receptor-3 (FGFR3) and therapeutic uses
专利权人:
Immunogen Inc.;Imclone LLC
发明人:
Balderes, Paul J.,Eastman, Scott W.,Erickson, Hans K.,Lugwig, Dale L.,Moxham, Christopher M.,Plowman, Gregory D.,Rigby, Alan C.
申请号:
AU2014366359
公开号:
AU2014366359A1
申请日:
2014.12.11
申请国别(地区):
AU
年份:
2016
代理人:
摘要:
The invention provides conjugates that consist of a drug moiety agent and a cell binding agent that target human fibroblast growth factor receptor 3 (FGFR3). These conjugates have therapeutic use as they are designed and tailored to target a specific cell population and deliver a powerful cytotoxin inside the cell. The conjugate of the present invention has significant advantages over other conjugates known in the art by providing a targeted tumor therapy as well as bystander activity to neighboring cells in an important oncology receptor that is only moderately expressed.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充